HPAPI 2018

HPAPI 2018


On 18 & 19 October 2018, Prague (Czech Republic) will host the BioTech Pharma Summit: HPAPI 2018 conference. This year’s event is designed to be a one-stop shop for both large pharma and smaller biotech organizations to gain all the developmental, safety and commercial information they require to enhance their HPAPI development for the year ahead.

Gain the technical expertise of process and analytical chemists working on overcoming early process development, scale up and technology transfer challenges encountered in the early stages of potent compound development.

It’s clear that significant organizational siloes exist within the HPAPI value chain, preventing the establishment of safe and effective practices early on in development. In order to combat this, this meeting will unite stakeholders at every stage of the value chain, breaking down these siloes and presenting you with a comprehensive insight into the development of potent compounds.

HPAPI 2018 will enable you to develop HPAPIs more efficiently, safely and cost-effectively than ever before. Whether you are involved in process development, scale up, occupational safety or outsourcing, this meeting will provide you with a wealth of actionable insights.


The BioTech Pharma Summit: HPAPI 2018 will bring together perspectives from every stage of the drug development value chain – from bench to point of outsource – providing you with a unified outlook on the latest developments in highly potent manufacturing.



  • HPAPI’s chemical manufacturing
  • Containment, equipment and facility design
  • Occupational EH&S Toxicological limits
  • Latest containment technologies and handling
  • Containment strategies for high potency APIs
  • Scale-up of HPAPIs and their Unique Challenges
  • CMC Development Projects
  • Formulation considerations for Highly Potent Active Pharmaceutical Ingredients
  • Antibody drug conjugates
  • Cross contamination risk assessment in multi-product facilities
  • Preventing Cross Contamination & Employee Exposures
  • Risk assessment in HPAPIs
  • Implementation of the ICH M7 Guideline
  • EMA Guideline on setting health based exposure limits
  • Performance to Plan in the API industry
  • Prevention of cross contamination
  • Outsourcing a SME pharma perspective
  • Strategies for CMO selection
  • Navigating the EU/US regulatory landscape
  • Challenges for ADC business
  • Optimisation of outsourcing strategies


The BioTech Pharma Summit (EPM Group) are exclusive events consisting of world-class keynote addresses and presentations designed specifically for senior level attendees from research & academic institutions, clinical research institutions and hospital laboratories as well as major pharmaceutical and biotech companies based Worldwide. Delegates typically include CEOs, VPs, Drug developers, Academics and Researchers, CROs, Scientists and Medical Doctors of:

  • Business Development
  • Engineering
  • Environmental, Health & Safety (HSE)
  • External Supply
  • Formulation Development
  • Occupational Toxicology
  • Industrial Hygiene
  • Laboratory Services
  • Manufacturing
  • New Products
  • New Technologies
  • Outsourcing
  • Process Development
  • Product Quality
  • Regulatory
  • Research & Development
  • Risk Assessments
  • Sales Development
  • Strategic Development
  • Validation
Basic Package
Buy Ticket

Access to all Sessions

Access to all Networking Sessions

Cocktail Reception Included

Premium Package
Buy Ticket

Unique one-on-one meetings

Airport pick-up/drop-off

2 nights at the Hotel Venue

Basic Exhibition Package
Buy Ticket

3m2 exhibition space

1 Complementary ticket

25% discount for extra ticket

Premium Exhibition Package
Buy Ticket

6m2 exhibition space

1 Complementary ticket

2 nights at the Hotel Venue